Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis.
Yasunaka T, Takaki A, Yagi T, Iwasaki Y, Sadamori H, Koike K, Hirohata S, Tatsukawa M, Kawai D, Shiraha H, Miyake Y, Ikeda F, Kobashi H, Matsuda H, Shinoura S, Yoshida R, Satoh D, Utsumi M, Onishi T, Yamamoto K. Yasunaka T, et al. Among authors: yagi t. Hepatol Int. 2011 Mar 25;5(4):918-926. doi: 10.1007/s12072-011-9265-z. eCollection 2011 Dec. Hepatol Int. 2011. PMID: 21484119 Free PMC article.
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Takaki A, Yagi T, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Yasuda Y, Nakayama E, Miyake Y, Ikeda F, Shiraha H, Nouso K, Fujiwara T, Yamamoto K. Takaki A, et al. Among authors: yagi t. J Gastroenterol. 2013 Dec;48(12):1373-83. doi: 10.1007/s00535-013-0763-8. Epub 2013 Feb 23. J Gastroenterol. 2013. PMID: 23435670 Free PMC article.
Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.
Utsumi M, Takaki A, Umeda Y, Koike K, Napier SC, Watanabe N, Sadamori H, Shinoura S, Yoshida R, Nobuoka D, Yasunaka T, Nakayama E, Yamamoto K, Fujiwara T, Yagi T. Utsumi M, et al. Among authors: yagi t. Transpl Immunol. 2014 Jun;31(1):33-41. doi: 10.1016/j.trim.2014.05.006. Epub 2014 Jun 5. Transpl Immunol. 2014. PMID: 24907425
Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.
Tsuzaki R, Takaki A, Yagi T, Ikeda F, Koike K, Iwasaki Y, Shiraha H, Miyake Y, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Nobuoka D, Utsumi M, Nakayama E, Fujiwara T, Yamamoto K. Tsuzaki R, et al. Among authors: yagi t. Acta Med Okayama. 2014;68(5):291-302. doi: 10.18926/AMO/52898. Acta Med Okayama. 2014. PMID: 25338486 Free article.
Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
Takaki A, Yagi T, Iwasaki Y, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Umeda Y, Miyake Y, Terada R, Kobashi H, Sakaguchi K, Tanaka N, Shiratori Y. Takaki A, et al. Among authors: yagi t. Transplantation. 2007 Jan 27;83(2):231-3. doi: 10.1097/01.tp.0000246310.75638.86. Transplantation. 2007. PMID: 17264822 Clinical Trial.
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K. Tanaka S, et al. Among authors: yagi t. Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22488108 Free article.
2,317 results